FDA Hit With Suit Over Reporting Leeway For Clinical Trials
A New York University faculty member and a former U.S. Food and Drug Administration official have hit the agency with a suit challenging a rule they said relaxed the reporting requirements...To view the full article, register now.
Already a subscriber? Click here to view full article